TOBI Podhaler 224 Capsule Monthly Pack
Semantic Scholar uses AI to extract papers important to this topic.
A high treatment burden with nebulised therapies in cystic fibrosis (CF) patients is the major limitation for… Expand Tobramycin Inhalation Powder (TIP) is a spray-dried engineered particle formulation used in TOBI Podhaler, a drug-device… Expand The aerosol performance and delivery characteristics of tobramycin for the treatment of respiratory infection were evaluated… Expand Background In a 6-month clinical trial, TOBI Podhaler (TIP) has been shown to be safe and generally well tolerated compared to… Expand Tobramycin powder for inhalation (TOBI Podhaler or TIP) is approved for the treatment of Pseudomonas aeruginosa airway infection… Expand BACKGROUND
Cystic fibrosis (CF) is an inherited condition characterised by the abnormal transport of chloride ions across… Expand TOBI Podhaler is the first dry powder formulation of tobramycin for inhaled therapy of chronic Pseudomonas aeruginosa infection… Expand BACKGROUND
A light-porous-particle, dry-powder formulation of tobramycin was developed, using PulmoSphere® technology, to improve… Expand From its introduction, the antibiotic tobramycin has been an important tool in the management of persons with cystic fibrosis (CF… Expand espanolFUNDAMENTO: Evaluar la eficacia de tobramicina nebulizada �TOBI®� en la modificacion de la historia natural de la… Expand